⌘K
Loading ticker…
As of 2026-08-24, Cartesian Therapeutics, Inc. Common Stock (RNAC) has a 3-month relative strength percentile of 93 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.4%, relative volume 0.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
RNAC is held by 9 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $403K notional. Top 3 carry $466K.
Held by 17 ETFs · $5M across latest filings · largest weight 0.03% (IWC).
Top 9 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $3K |
| — |
| UWM | 0.00% | $3K | — |
| HDG | 0.00% | $83 | — |
| RB | 0.00% | $15 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RNAC Jan avg: 2.33% median: 4.44% win: 67% σ: 6.79% n: 3 2023-11-15 → 2026-07-31 | RNAC Feb avg: 3.43% median: 1.60% win: 67% σ: 6.96% n: 3 2023-11-15 → 2026-07-31 | RNAC Mar avg: -20.05% median: -18.97% win: 0% σ: 9.50% n: 3 2023-11-15 → 2026-07-31 | RNAC Apr avg: 1.79% median: 1.14% win: 67% σ: 11.08% n: 3 2023-11-15 → 2026-07-31 | RNAC May avg: 19.40% median: 21.22% win: 67% σ: 38.86% n: 3 2023-11-15 → 2026-07-31 | RNAC Jun avg: 8.22% median: 8.68% win: 67% σ: 30.20% n: 3 2023-11-15 → 2026-07-31 | RNAC Jul avg: -13.84% median: -25.14% win: 33% σ: 32.96% n: 3 2023-11-15 → 2026-07-31 | RNAC Aug avg: -17.95% median: -17.95% win: 0% σ: 5.08% n: 2 2023-11-15 → 2026-07-31 (current) | RNAC Sep avg: 8.58% median: 8.58% win: 100% σ: 9.74% n: 2 2023-11-15 → 2026-07-31 | RNAC Oct avg: 1.39% median: 1.39% win: 50% σ: 30.33% n: 2 2023-11-15 → 2026-07-31 | RNAC Nov avg: 4.32% median: -4.90% win: 33% σ: 19.00% n: 3 2023-11-15 → 2026-07-31 | RNAC Dec avg: -2.16% median: -3.74% win: 33% σ: 3.77% n: 3 2023-11-15 → 2026-07-31 |